Redox‐Active Nanozymes in Metabolic Modulation for Precision Therapeutics
Advanced Healthcare Materials · 2026-01 · 15 (2)
DOI: 10.1002/adhm.202502110 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 13.09.2025. Verfasst von Wenying Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, Ch…. Hauptthemen laut MEDLINE: Precision Medicine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 159 Literaturangaben. Gefördert von: science and technology development plan of Jilin province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Nanozyme metabolic therapy leverages the catalytic activity of artificial enzymes to reprogram dysregulated metabolic pathways at disease sites, offering a targeted approach to restore physiological homeostasis. This review uniquely focuses on redox‐active nanozymes and their roles in modulating key metabolic circuits (e.g., glucose, lactate, lipid, and xanthine metabolism) across diverse pathological contexts. While cancer remains the most extensively explored domain, emerging uses of nanozymes in bacterial infections, cardiovascular diseases, diabetes, obesity, and inflammatory disorders, where mechanistic understanding is still evolving, are also highlighted. By selectively altering metabolite levels and enzymatic activities, nanozymes enable precise metabolic control with high catalytic specificity. Nanozymes are systematically categorized based on their redox mechanisms and the metabolic pathways they influence, and discuss representative examples across disease contexts. Finally, the review concludes by outlining current challenges and emphasizing the translational potential of nanozymes as programmable metabolic modulators, aiming to expand their impact beyond oncology into broader clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, China.
- State Key Laboratory of New Textile Materials and Advanced Processing, College of Materials Science and Engineering, Wuhan Textile University, Wuhan, 430200, China.
ORCID-Profile: Ping'an Ma
Förderung
- science and technology development plan of Jilin province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, W., Wang, M., Ma, P., & Lin, J. (2026). Redox‐Active Nanozymes in Metabolic Modulation for Precision Therapeutics. Advanced Healthcare Materials, 15(2). https://doi.org/10.1002/adhm.202502110
Vancouver
Zhang W, Wang M, Ma P, Lin J. Redox‐Active Nanozymes in Metabolic Modulation for Precision Therapeutics. Advanced Healthcare Materials. 2026;15(2). doi:10.1002/adhm.202502110
BibTeX
@article{Zhang2026,
author = {Zhang, Wenying and Wang, Meifang and Ma, Ping'an and Lin, Jun},
title = {Redox‐Active Nanozymes in Metabolic Modulation for Precision Therapeutics},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {2},
doi = {10.1002/adhm.202502110}
}
EUVIMED